Atika Capital Management’s Roivant Sciences ROIV Stock Holding History

Atika Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.68M	Buy	+217,000	New	+$6.41M	0.5%	50
2024 Q3	–	Sell	-400,000	Closed	-$4.23M	–	112
2024 Q2	$4.23M	Sell	400,000 -134,980	-25%	-$1.48M	0.41%	68
2024 Q1	$5.64M	Sell	534,980 -205,000	-28%	-$2.21M	0.56%	61
2023 Q4	$8.31M	Buy	739,980 +194,980	+36%	+$1.9M	1.11%	34
2023 Q3	$6.37M	Buy	545,000 +146,500	+37%	+$1.66M	0.84%	47
2023 Q2	$4.02M	Sell	398,500 -86,500	-18%	-$774K	0.4%	69
2023 Q1	$3.58M	Sell	485,000 -75,000	-13%	-$618K	0.53%	56
2022 Q4	$4.47M	Buy	+560,000	New	+$3.12M	0.64%	49

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Atika Capital Management's ROIV Position: Q2 2026 in Review

Atika Capital Management opened a new position in Roivant Sciences (ROIV) in Q2 2026: 217,000 shares worth $7.68M. The stake represents 0.5% of the portfolio and ranks #50 among its holdings. This is a return to the name: Atika Capital Management previously reported a position in ROIV as recently as Q2 2024.

Atika Capital Management first reported a position in ROIV in Q4 2022 and has held it in 8 quarters since. The position peaked at $8.31M in Q4 2023. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Atika Capital Management held 217,000 shares of Roivant Sciences worth $7.68M as of Q2 2026.
Roivant Sciences was a new Atika Capital Management position in Q2 2026.
Roivant Sciences made up 0.5% of Atika Capital Management's portfolio in Q2 2026, its #50 holding.
Atika Capital Management first reported a position in Roivant Sciences in Q4 2022 and has held it in 8 quarters since.
Atika Capital Management's Roivant Sciences position peaked at $8.31M in Q4 2023.
499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Atika Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.